CSL (ASX:CSL) Insider Carolyn Hewson Buys 244 Shares

CSL Limited (ASX:CSL) insider Carolyn Hewson bought 244 shares of the company’s stock in a transaction on Tuesday, February 17th. The shares were bought at an average cost of A$151.56 per share, for a total transaction of A$36,979.91.

CSL Price Performance

The company has a current ratio of 1.86, a quick ratio of 1.68 and a debt-to-equity ratio of 64.46. The firm has a market capitalization of $77.43 billion, a PE ratio of 28.02, a price-to-earnings-growth ratio of 1.29 and a beta of 0.32.

CSL Dividend Announcement

The company also recently announced a Interim dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, April 8th will be paid a $1.837 dividend. The ex-dividend date is Monday, March 9th. This represents a yield of 121.0%. CSL’s dividend payout ratio (DPR) is 50.38%.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology.